Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT02198573 |
Date of registration:
|
22/07/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar
|
Scientific title:
|
Molecular Assessment of Artemisinin Resistance Markers, K13 Kelch Propeller and Multi-drug Resistant Gene Polymorphism in Eastern and Western Border Areas of Myanmar |
Date of first enrolment:
|
July 2013 |
Target sample size:
|
91 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT02198573 |
Study type:
|
Observational |
Study design:
|
Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Myanmar
| | | | | | | |
Contacts
|
Name:
|
Myat P Kyaw, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Department of Medical Research, Lower Myanmar |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- confirmed uncomplicated falciparum malaria patients.
- age >2 years
- box sex
- given informed consent
Exclusion Criteria:
- severe malaria
- did not give informed consent
- others diseases
Age minimum:
2 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Prevalence of Drug Resistance Gene Mutation
|
Day-3 Positive of Parasitaemia
|
Primary Outcome(s)
|
day-3 parasite positivity
[Time Frame: 3 days]
|
Secondary Outcome(s)
|
Prevalence of the drug resistance marker
[Time Frame: up to day-3]
|
Secondary ID(s)
|
WHO_3DF_2013_day3
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|